- In April 2024, Abcam plc launched its next-generation oxidative stress assay kits, designed to enhance accuracy and throughput in drug discovery and disease mechanism research. These new kits enable scientists to quantify oxidative damage in live cells with improved sensitivity and reproducibility, reinforcing Abcam’s role as a key player in redox biology solutions
- In January 2024, Cayman Chemical Company announced the expansion of its oxidative stress assay portfolio with new products for mitochondrial ROS detection and lipid peroxidation assays. These tools are aimed at helping researchers better understand oxidative damage mechanisms in metabolic and neurodegenerative diseases
- In October 2023, Thermo Fisher Scientific introduced automated high-throughput oxidative stress assays compatible with its Gibco CellInsight CX7 HCS platform, supporting multiparametric readouts for use in toxicology, pharmacology, and environmental studies. This development is intended to help pharma companies reduce assay variability and improve efficiency
- In June 2022, Dojindo, Japan launched the ROS Assay Kit for Photo-oxidation Resistant DCFH-DA. DCFH-DA is widely used for Reactive Oxygen Species detection
- In February 2022, Invitae introduced FusionPlex Dx and LiquidPlex Dx in Europe. FusionPlex Dx is intended to be used as a CDx to aid in identifying patients diagnosed with NSCLC with ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) fusions, and others for whom treatment with targeted therapy may be beneficial
